Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1

Clinical trial NCT02620280 · COMPLETED

Trial details

NCT number: NCT02620280
Sponsor: Fondazione Michelangelo
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Invasive Ductal Breast Carcinoma

Start date: 2016-04-01
Primary completion: 2024-01-01
Enrollment: 278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.